THE IMPACT OF DIABETES ON EJECTION FRACTION IN PATIENTS WITH ADVANCED CORONARY ARTERY DISEASE

Sabina Brazevič1, Magdalena Grajek1, Tomasz Kopyciuk1

1 Faculty of Physics, Adam Mickiewicz University in Poznań

Morbidity due to all forms of coronary heart disease is a function of the combination of several cardiovascular risk factors: smoking, hypertension, left ventricular hypertrophy and diabetes [1]. The first signs of ischemia, infarction and heart failure faster reveal in diabetic patients, especially after a few years of the disease or with the poorly therapy. [2] In patients with diabetes and ischemic heart disease the prognosis is 2-3 times worse than the general population and the number of patients increases every year. [3] [4]

The major problem in general is the course of the disease and the selection of treatment: insulin or treatment medicaments. Due to the disease left ventricular performance is often limited and echocardiography method allows to check it out using ultrasound. Determination of ejection fraction allows to assess the state of the left ventricle.

This parameter (EF) was used to check the condition of the patient after coronary artery bypass grafting (CABG) in patients with diabetes treated with two methods: insulin or drugs.

A group of 186 patients, which included 46 patients with diabetes was studied. The main goal of this work was to check whether the ejection fraction of the left ventricle may be an important determinant of prognosis the course of convalescence after CABG surgery and thus whether it will be a good parameter determining the severity of coronary disease among people with diabetes.


[1] Koblik T., Insulinotherapy in diabetes type 2, Via Medica, Gdańsk 2010, ISBN 978-83-7555-214-0

[2] Cichocka A., A practical guide to weight loss and nutritional prevention and treatment of diabetes type 2, Medyk, Warsaw 2010, ISBN 978-83-89745-58-3

[3] Tatoń J., Management of diabetes type 2 based on evidence - standards for doctors, PZWL, Warsaw 2002, ISBN 83-200-2707-1

[4] American Diabetes Association, Treatment of diabetes type 2, Via Medica, Gdańsk 2002, ISBN 83-7258-086-3